Goldman Sachs Group Inc Alkermes Plc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,667,697 shares of ALKS stock, worth $51.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,667,697
Previous 1,472,051
13.29%
Holding current value
$51.6 Million
Previous $48.6 Million
1.84%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding ALKS
# of Institutions
393Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$901 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$573 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$311 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$254 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$198 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.08B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...